CTIS.eu › Cities › Italy › Modena
Modena
Italy
360 total trials
155 recruiting
2022-501417-31-00
5
High-risk Resected Melanoma
2023-504641-32-00
4
Post-acute COVID syndrome(PACS) diagnosis.
2022-502779-40-99
5
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
2023-503676-25-01
4
prostate cancer
2024-514246-37-00
4
Idiopathic pulmonary fibrosis (IPF)
2024-514355-16-01
5
Acute Respiratory Distress Syndrome (ARDS)
2024-514701-57-01
4
non Small Cell Lung Cancer
2024-515202-84-00
10
Anemia in subjects with sickle cell disease (SCD)
2024-516076-15-00
3
Infants with perinatal asphyxiation and indication to hypothermic trea
2024-516731-27-00
5
Ischemic stroke patients with secondary post-rtPA hypofibrinogenemia
2024-517339-30-00
7
Advanced Solid Tumors
2024-517796-21-00
5
Prevention of recurrence after a first episode of Venous Thromboemboli
2024-517861-18-00
5
Idiopathic IgA nephropathy (IgAN)
2024-518013-25-00
4
Idiopathic Pulmonary Fibrosis
2024-518026-32-00
5
Invasive Breast Cancer
2024-518386-95-02
4
Non small-cell lung cancer
2024-518388-37-00
4
Intermediate risk prostate cancer
2024-518821-13-00
4
Non-cystic Fibrosis Bronchiectasis
2024-519087-41-00
5
Breast cancer is the most common form of cancer among women in North A
2024-519106-12-00
4
Patients with anaplastic lymphoma kinase positive (ALK+) locally advan
2024-519403-10-00
6
Female contraception.
2024-519638-22-00
5
IgA nephropathy
2024-519655-28-00
5
Premenopausal patients with high-risk HR-positive/HER2-negative breast
2024-520081-65-00
4
NSCLC non-small cell lung cancer
Showing 1–24 of 360 trials